147.72
price up icon1.03%   1.50
after-market Handel nachbörslich: 148.32 0.60 +0.41%
loading
Schlusskurs vom Vortag:
$146.22
Offen:
$147.37
24-Stunden-Volumen:
1.37M
Relative Volume:
0.86
Marktkapitalisierung:
$21.66B
Einnahmen:
$9.61B
Nettoeinkommen (Verlust:
$1.53B
KGV:
14.13
EPS:
10.453
Netto-Cashflow:
$1.85B
1W Leistung:
+2.83%
1M Leistung:
+5.02%
6M Leistung:
+24.25%
1J Leistung:
-20.54%
1-Tages-Spanne:
Value
$146.25
$149.12
1-Wochen-Bereich:
Value
$141.67
$149.12
52-Wochen-Spanne:
Value
$110.03
$187.58

Biogen Inc Stock (BIIB) Company Profile

Name
Firmenname
Biogen Inc
Name
Telefon
(781) 464-2000
Name
Adresse
225 BINNEY STREET, CAMBRIDGE, MA
Name
Mitarbeiter
7,605
Name
Twitter
@biogen
Name
Nächster Verdiensttermin
2024-10-30
Name
Neueste SEC-Einreichungen
Name
BIIB's Discussions on Twitter

Vergleichen Sie BIIB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
BIIB
Biogen Inc
147.72 21.44B 9.61B 1.53B 1.85B 10.45
Drug Manufacturers - General icon
LLY
Lilly Eli Co
812.43 716.78B 53.26B 13.80B -50.20M 15.08
Drug Manufacturers - General icon
JNJ
Johnson Johnson
192.94 462.11B 92.15B 25.12B 18.18B 10.36
Drug Manufacturers - General icon
ABBV
Abbvie Inc
228.68 408.76B 58.33B 3.73B 18.24B 2.1013
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
131.43 254.25B 53.40B 13.68B 16.89B 6.8864
Drug Manufacturers - General icon
MRK
Merck Co Inc
87.61 218.86B 63.43B 16.42B 14.72B 6.4861

Biogen Inc Stock (BIIB) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-25 Eingeleitet Jefferies Buy
2025-07-21 Fortgesetzt Truist Hold
2025-04-28 Herabstufung HSBC Securities Buy → Hold
2025-04-04 Herabstufung Argus Buy → Hold
2025-02-11 Eingeleitet Bernstein Mkt Perform
2025-01-02 Herabstufung Piper Sandler Overweight → Neutral
2024-12-20 Herabstufung BMO Capital Markets Outperform → Market Perform
2024-12-16 Herabstufung Stifel Buy → Hold
2024-12-10 Fortgesetzt BofA Securities Neutral
2024-12-09 Herabstufung Jefferies Buy → Hold
2024-11-18 Herabstufung Needham Buy → Hold
2024-11-15 Eingeleitet Wolfe Research Peer Perform
2024-11-14 Eingeleitet Citigroup Neutral
2024-10-31 Herabstufung Morgan Stanley Overweight → Equal-Weight
2024-10-10 Fortgesetzt Raymond James Mkt Perform
2024-02-14 Bestätigt Needham Buy
2024-02-14 Herabstufung Wells Fargo Overweight → Equal Weight
2024-01-24 Herabstufung UBS Buy → Neutral
2023-12-20 Fortgesetzt Cantor Fitzgerald Overweight
2023-12-07 Hochstufung Raymond James Mkt Perform → Outperform
2023-09-06 Eingeleitet HSBC Securities Buy
2023-07-27 Eingeleitet Scotiabank Sector Outperform
2023-07-24 Bestätigt UBS Buy
2023-05-01 Hochstufung Guggenheim Neutral → Buy
2023-04-17 Hochstufung Piper Sandler Neutral → Overweight
2022-10-26 Hochstufung Goldman Neutral → Buy
2022-10-13 Hochstufung Stifel Hold → Buy
2022-10-07 Hochstufung Argus Hold → Buy
2022-09-28 Hochstufung BMO Capital Markets Market Perform → Outperform
2022-09-28 Hochstufung Mizuho Neutral → Buy
2022-09-28 Hochstufung Robert W. Baird Neutral → Outperform
2022-04-18 Hochstufung Wells Fargo Equal Weight → Overweight
2022-03-08 Herabstufung Stifel Buy → Hold
2022-03-03 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2022-02-04 Herabstufung BMO Capital Markets Outperform → Market Perform
2022-02-04 Bestätigt Barclays Equal Weight
2022-02-04 Bestätigt BofA Securities Neutral
2022-02-04 Bestätigt Cowen Outperform
2022-02-04 Bestätigt Morgan Stanley Overweight
2022-02-04 Bestätigt Needham Buy
2022-02-04 Bestätigt Oppenheimer Outperform
2022-02-04 Bestätigt RBC Capital Mkts Sector Perform
2022-02-04 Bestätigt Robert W. Baird Neutral
2022-02-04 Bestätigt Wedbush Neutral
2022-02-04 Bestätigt Wells Fargo Equal Weight
2022-02-04 Bestätigt Wolfe Research Peer Perform
2022-01-13 Herabstufung Guggenheim Buy → Neutral
2022-01-12 Herabstufung Piper Sandler Overweight → Neutral
2021-12-10 Fortgesetzt Raymond James Mkt Perform
2021-12-09 Fortgesetzt Wells Fargo Equal Weight
2021-12-06 Eingeleitet Goldman Neutral
2021-11-19 Eingeleitet BMO Capital Markets Outperform
2021-09-23 Eingeleitet Needham Buy
2021-06-18 Hochstufung Piper Sandler Neutral → Overweight
2021-06-14 Bestätigt Truist Buy
2021-06-11 Hochstufung Bernstein Mkt Perform → Outperform
2021-06-10 Hochstufung UBS Neutral → Buy
2021-06-08 Hochstufung Atlantic Equities Underweight → Neutral
2021-06-08 Bestätigt Barclays Equal Weight
2021-06-08 Hochstufung Citigroup Sell → Neutral
2021-06-08 Bestätigt H.C. Wainwright Buy
2021-06-08 Bestätigt Jefferies Buy
2021-06-08 Bestätigt Morgan Stanley Overweight
2021-06-08 Bestätigt RBC Capital Mkts Sector Perform
2021-06-08 Hochstufung Robert W. Baird Underperform → Neutral
2021-06-08 Bestätigt Stifel Buy
2021-06-08 Hochstufung William Blair Mkt Perform → Outperform
2021-06-07 Hochstufung BofA Securities Underperform → Neutral
2021-06-07 Hochstufung Cowen Market Perform → Outperform
2021-06-07 Hochstufung Raymond James Underperform → Mkt Perform
2021-02-05 Herabstufung DZ Bank Buy → Hold
2021-01-29 Hochstufung Stifel Hold → Buy
2020-11-10 Hochstufung DZ Bank Hold → Buy
2020-11-09 Herabstufung Atlantic Equities Neutral → Underweight
2020-11-09 Herabstufung BofA Securities Neutral → Underperform
2020-11-09 Herabstufung Cowen Outperform → Market Perform
2020-11-09 Bestätigt H.C. Wainwright Buy
2020-11-04 Hochstufung BofA Securities Underperform → Neutral
2020-11-04 Hochstufung Jefferies Hold → Buy
2020-11-04 Hochstufung Wells Fargo Equal Weight → Overweight
2020-10-28 Eingeleitet UBS Neutral
2020-07-27 Hochstufung Morgan Stanley Underweight → Overweight
2020-06-22 Herabstufung Barclays Overweight → Equal Weight
2020-06-22 Bestätigt RBC Capital Mkts Sector Perform
2020-06-09 Herabstufung Bernstein Outperform → Mkt Perform
2020-04-23 Herabstufung Citigroup Neutral → Sell
2020-04-23 Herabstufung Raymond James Mkt Perform → Underperform
2020-03-31 Eingeleitet Wolfe Research Peer Perform
2020-02-27 Eingeleitet Barclays Overweight
2020-01-27 Hochstufung Canaccord Genuity Hold → Buy
2019-12-13 Hochstufung Credit Suisse Underperform → Neutral
2019-12-02 Herabstufung Robert W. Baird Neutral → Underperform
Alle ansehen

Biogen Inc Aktie (BIIB) Neueste Nachrichten

pulisher
08:40 AM

Biogen (BIIB) Highlights Promising Results of Dapirolizumab Pego - GuruFocus

08:40 AM
pulisher
08:39 AM

Biogen to present dapirolizumab pegol SLE study results at ACR - Investing.com

08:39 AM
pulisher
08:26 AM

Biogen (BIIB) Valuation in Focus After New Dravet Syndrome Data Shows Extended Clinical Benefit - simplywall.st

08:26 AM
pulisher
08:15 AM

Citizens & Northern Corp Has $883,000 Stake in Biogen Inc. $BIIB - MarketBeat

08:15 AM
pulisher
08:00 AM

Cassava Sciences Appoints Dawn C. Bir to the Board of Directors - GlobeNewswire Inc.

08:00 AM
pulisher
07:42 AM

Biogen Announces Phase 3 Study Results of Dapirolizumab Pegol in Systemic Lupus Erythematosus to Be Presented at ACR Convergence 2025 - Quiver Quantitative

07:42 AM
pulisher
07:31 AM

Biogen to Present Additional Results from Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus at ACR Convergence 2025 - Biogen

07:31 AM
pulisher
06:56 AM

How Biogen Inc. (IDP) stock behaves in tightening cyclesWeekly Profit Analysis & Free Daily Entry Point Trade Alerts - newser.com

06:56 AM
pulisher
03:55 AM

Mutual Advisors LLC Acquires New Shares in Biogen Inc. $BIIB - MarketBeat

03:55 AM
pulisher
12:44 PM

Using data filters to optimize entry into Biogen Inc.2025 Market Trends & Community Consensus Stock Picks - newser.com

12:44 PM
pulisher
Oct 21, 2025

Will Biogen Inc. (IDP) stock benefit from commodity supercycle2025 Winners & Losers & Safe Swing Trade Setup Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Historical volatility pattern of Biogen Inc. visualizedVolume Spike & AI Driven Stock Reports - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Institutional scanner results for Biogen Inc.July 2025 Analyst Calls & Verified Stock Trade Ideas - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Sector ETF performance correlation with Biogen Inc.July 2025 Macro Moves & Real-Time Volume Triggers - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Can Biogen Inc. stock double in next 5 yearsQuarterly Profit Report & Free Safe Capital Growth Stock Tips - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Biogen Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛

Oct 21, 2025
pulisher
Oct 21, 2025

20,500 Shares in Biogen Inc. $BIIB Acquired by Privium Fund Management B.V. - MarketBeat

Oct 21, 2025
pulisher
Oct 21, 2025

Is it time to cut losses on Biogen Inc.2025 Key Highlights & Risk Controlled Stock Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Is Biogen Inc. stock a top momentum playPortfolio Risk Summary & Low Drawdown Trading Techniques - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Volatility clustering patterns for Biogen Inc.July 2025 Outlook & Fast Exit/Entry Strategy Plans - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

How to escape a deep drawdown in Biogen Inc.Market Sentiment Summary & Safe Entry Zone Tips - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Lobbying Update: $990,000 of BIOGEN lobbying was just disclosed - Quiver Quantitative

Oct 20, 2025
pulisher
Oct 20, 2025

Is Biogen Inc. (IDP) stock a buy on weakness2025 Breakouts & Breakdowns & Consistent Income Trade Ideas - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Key metrics from Biogen Inc.’s quarterly dataBreakout Watch & Weekly High Return Stock Forecasts - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Biogen Inc.’s volatility index tracking explainedJobs Report & Long Hold Capital Preservation Plans - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

J.L. Bainbridge Exits Most of Biogen Stake as Biotech Stock Eyes Turnaround - AOL.com

Oct 20, 2025
pulisher
Oct 20, 2025

Is a relief rally coming for Biogen Inc. holdersTrade Volume Summary & AI Powered Buy and Sell Recommendations - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Biogen (BIIB) breakout and retrace signals buying opportunity - FXStreet

Oct 20, 2025
pulisher
Oct 20, 2025

Nordea Investment Management AB Purchases 6,811 Shares of Biogen Inc. $BIIB - MarketBeat

Oct 20, 2025
pulisher
Oct 20, 2025

Is Biogen Inc. stock a safe buy before earningsJuly 2025 Opening Moves & Weekly Momentum Stock Picks - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Is Biogen Inc. forming a reversal patternJuly 2025 Short Interest & Breakout Confirmation Trade Signals - newser.com

Oct 20, 2025
pulisher
Oct 19, 2025

New York State Teachers Retirement System Has $13.90 Million Stock Holdings in Biogen Inc. $BIIB - MarketBeat

Oct 19, 2025
pulisher
Oct 19, 2025

Ritholtz Wealth Management Buys Shares of 6,076 Biogen Inc. $BIIB - MarketBeat

Oct 19, 2025
pulisher
Oct 18, 2025

Will LEQEMBI IQLIK’s At-Home Launch Redefine Biogen’s (BIIB) Alzheimer’s Treatment Story? - simplywall.st

Oct 18, 2025
pulisher
Oct 18, 2025

Is Biogen Inc. stock a buy before product launchesQuarterly Growth Report & Smart Swing Trading Alerts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Gains Report: Is Biogen Inc. stock a buy before product launchesProduct Launch & Safe Entry Momentum Tips - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Applied Finance Capital Management LLC Invests $465,000 in Biogen Inc. $BIIB - MarketBeat

Oct 18, 2025
pulisher
Oct 18, 2025

TD Asset Management Inc Has $17.96 Million Holdings in Biogen Inc. $BIIB - MarketBeat

Oct 18, 2025
pulisher
Oct 18, 2025

Yousif Capital Management LLC Has $2.48 Million Stock Holdings in Biogen Inc. $BIIB - MarketBeat

Oct 18, 2025
pulisher
Oct 18, 2025

Is Biogen Inc. stock a defensive play in 20252025 Historical Comparison & AI Forecast Swing Trade Picks - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Gains Recap: Is Biogen Inc. stock a buy before product launchesTrade Performance Summary & Short-Term Trading Opportunity Alerts - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

How Biogen Inc. stock compares to market leadersTreasury Yields & Reliable Trade Execution Plans - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Using portfolio simulators with Biogen Inc. includedQuarterly Trade Review & Stock Market Timing Techniques - newser.com

Oct 17, 2025
pulisher
Oct 17, 2025

Biogen (BIIB) Gains Momentum with Patient Opportunity Equity Str - GuruFocus

Oct 17, 2025
pulisher
Oct 17, 2025

Wedbush Has Optimistic Outlook of Biogen Q1 Earnings - MarketBeat

Oct 17, 2025
pulisher
Oct 17, 2025

Allianz Asset Management GmbH Has $66.19 Million Position in Biogen Inc. $BIIB - MarketBeat

Oct 17, 2025
pulisher
Oct 17, 2025

Cwm LLC Acquires 6,639 Shares of Biogen Inc. $BIIB - MarketBeat

Oct 17, 2025
pulisher
Oct 17, 2025

Callan Family Office LLC Purchases Shares of 2,454 Biogen Inc. $BIIB - MarketBeat

Oct 17, 2025
pulisher
Oct 17, 2025

Biogen Inc. Stock Falls by 3.65% - Idéal Investisseur

Oct 17, 2025
pulisher
Oct 16, 2025

Is Biogen Now an Opportunity After Recent 25% Share Price Decline? - simplywall.st

Oct 16, 2025

Finanzdaten der Biogen Inc-Aktie (BIIB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_general SNY
$49.99
price up icon 0.66%
drug_manufacturers_general PFE
$24.72
price down icon 0.52%
$121.46
price down icon 2.11%
$295.98
price down icon 1.71%
drug_manufacturers_general NVO
$53.38
price down icon 2.56%
drug_manufacturers_general MRK
$87.61
price down icon 0.01%
Kapitalisierung:     |  Volumen (24h):